Your browser doesn't support javascript.
loading
Less frequent rituximab retreatment maintains remission of neuromyelitis optica spectrum disorder, following long-term rituximab treatment.
Kim, Su-Hyun; Kim, Yeseul; Kim, Gayoung; Park, Na Young; Jang, Hyun-Min; Shin, Hyun-June; Hyun, Jae-Won; Kim, Ho Jin.
  • Kim SH; Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, South Korea.
J Neurol Neurosurg Psychiatry ; 90(4): 486-487, 2019 04.
Article en En | MEDLINE | ID: mdl-29929977
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neuromielitis Óptica / Rituximab / Factores Inmunológicos Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neuromielitis Óptica / Rituximab / Factores Inmunológicos Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article